(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Esomeprazole: Oral capsule, gastro-resistant pellets (20mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_22450.JPG
Esomeprazole 20mg DR Cap
Mylan Pharmaceuticals Inc.
Pill Identification: M150 M150 
Drug Image file DrugItem_20605.JPG
Esomeprazole 20mg DR Cap
Teva Pharmaceuticals USA
Pill Identification: LOGO 6450 20 mg 
Drug Image file default-drug-image.png
Esomeprazole 20mg DR Cap
Drug Image file default-drug-image.png
Esomeprazole 20mg DR Cap

What is this Medicine?

ESOMEPRAZOLE (es oh ME pray zol) prevents the production of acid in the stomach. It is used to treat gastroesophageal reflux disease (GERD), ulcers, certain bacteria in the stomach, and inflammation of the esophagus. It can also be used to prevent ulcers in patients taking medicines called NSAIDs.

You can also buy this medicine without a prescription to treat the symptoms of heartburn. The non-prescription product is not for long-term use, unless otherwise directed by your doctor or health care professional.

CVS Pharmacy Patient Statistics for Esomeprazole: Oral capsule, gastro-resistant pellets(20mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Esomeprazole Magnesium 20mg Delayed-Release Capsule

NDC: 003782350
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Esophagitis, Helicobacter Pylori (H. Pylori) Eradication, Dyspepsia, NSAID-induced Ulcer Prophylaxis, Zollinger-Ellison Syndrome, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD), Pyrosis (heartburn)

Sometimes used for but not FDA approved for the following conditions:
Gastric Ulcer, Eosinophilic Esophagitis

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Esomeprazole Magnesium 20mg Delayed-Release Capsule
Drug Image file DrugItem_22450.JPG
Mylan Pharmaceuticals Inc.
Pill Identification: M150 M150 
Shape: capsule
Color: white

Reported Side Effects for Esomeprazole Magnesium 20mg Delayed-Release Capsule

Flushing Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Belching Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
<2.5%*
Severity: MILD
Onset: EARLY
Diaphoresis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Conjunctivitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Blurred Vision Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Back Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Arthropathy Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Causing To Be Hungry Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Inceased Urination Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Fluid Retention Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Cramps Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Irregular Periods Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High White Blood Cells Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Blood In The Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Intestinal Bleeding Incidence:
<4.3%*
Severity: SEVERE
Onset: DELAYED
Weight Loss Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Weight Gain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Visual Impairment Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Rhinitis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Itching Around The Anus Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Excessive Thirst Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Parosmia Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Paresthesias Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Melena Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Feeling Sick Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rash With Pustules Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Enlarged Lymph Nodes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Increased Urination Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Impotence (erectile Dysfunction) Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Hypoesthesia Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Excessive Mucle Tone Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Hiccups Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Glycosuria Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Hot Flashes Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Enlarged Thyroid Gland Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Swelling Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Painful Urination Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Shortness Of Breath Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Upset Stomach Incidence:
<6.4%*
Severity: MILD
Onset: EARLY
Menstrual Cramps Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Drowsiness Incidence:
<1.9%*
Severity: MILD
Onset: EARLY
Depression Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Bladder Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Yeast Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Anemia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Acne Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Difficulty Swallowing Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Balance Problems Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Vaginal Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Shaking Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Ringing In Ears Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Mouth Ulcers Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
<1.1%*
Severity: MILD
Onset: RAPID
Sore Throat Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
High Bilirubin Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
High Uric Acid Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Migraine Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Constipation Incidence:
1.0-2.5%*
Severity: MODERATE
Onset: DELAYED
Sinus Infection Incidence:
1.0-1.7%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
1.0-4.3%*
Severity: MILD
Onset: EARLY
Gas Incidence:
1.0-10.3%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
1.0-3.9%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
1.0-5.8%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.0-6.4%*
Severity: MILD
Onset: EARLY
Infection Incidence:
1.1%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
1.9-10.9%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Esomeprazole

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.